scholarly article | Q13442814 |
P356 | DOI | 10.1002/PATH.4887 |
P698 | PubMed publication ID | 28191908 |
P50 | author | Léo Laoubi | Q48248139 |
Marc Vocanson | Q63430303 | ||
Jean Francois Nicolas | Q67516855 | ||
Aurore Rozieres | Q79711937 | ||
Marie-Florence Galliano | Q96211986 | ||
P2093 | author name string | Catherine Goujon | |
Béatrice Guiraud | |||
Cédric Carrasco | |||
Hélène Duplan | |||
Marine Bernard | |||
Sandrine Bessou-Touya | |||
P2860 | cites work | Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin | Q24317035 |
Inducible expression of the proallergic cytokine thymic stromal lymphopoietin in airway epithelial cells is controlled by NFkappaB | Q24682171 | ||
A molecular signature of epithelial host defense: comparative gene expression analysis of cultured bronchial epithelial cells and keratinocytes. | Q25256845 | ||
Staphylococcus aureus alpha-hemolysin activates the NLRP3-inflammasome in human and mouse monocytic cells | Q33510340 | ||
Human corneal epithelium-derived thymic stromal lymphopoietin links the innate and adaptive immune responses via TLRs and Th2 cytokines | Q33870391 | ||
Basophil responses to chemokines are regulated by both sequential and cooperative receptor signaling. | Q33928445 | ||
Sensing the outside world: TSLP regulates barrier immunity. | Q34076759 | ||
Mechanisms of IFN-γ-induced apoptosis of human skin keratinocytes in patients with atopic dermatitis | Q34263412 | ||
Profiling and metaanalysis of epidermal keratinocytes responses to epidermal growth factor | Q34580355 | ||
Constitutive and inducible thymic stromal lymphopoietin expression in human airway smooth muscle cells: role in chronic obstructive pulmonary disease | Q34629921 | ||
Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities | Q35084580 | ||
IL-31 Serum Protein and Tissue mRNA Levels in Patients with Atopic Dermatitis | Q35590354 | ||
Epidermal barrier in atopic dermatitis | Q35622183 | ||
Dichotomy of short and long thymic stromal lymphopoietin isoforms in inflammatory disorders of the bowel and skin | Q35947790 | ||
Airway epithelial cells activate TH2 cytokine production in mast cells through IL-1 and thymic stromal lymphopoietin | Q36069418 | ||
Interleukin-1α controls allergic sensitization to inhaled house dust mite via the epithelial release of GM-CSF and IL-33. | Q36131723 | ||
Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiency. | Q36770768 | ||
TSLP acts on infiltrating effector T cells to drive allergic skin inflammation | Q36954478 | ||
Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. Implications for sustained dendritic cell activation in the skin | Q37369087 | ||
Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunity. | Q37382279 | ||
Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis. | Q37709674 | ||
Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis | Q37709681 | ||
Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis | Q37822710 | ||
Contrasting pathogenesis of atopic dermatitis and psoriasis--part II: immune cell subsets and therapeutic concepts | Q37855007 | ||
Atopic dermatitis: from new pathogenic insights toward a barrier-restoring and anti-inflammatory therapy | Q37942281 | ||
TSLP expression: cellular sources, triggers, and regulatory mechanisms. | Q37978127 | ||
The cutaneous innate immune response in patients with atopic dermatitis. | Q38078473 | ||
The multifunctional role of filaggrin in allergic skin disease | Q38078474 | ||
Cytokines as therapeutic targets in skin inflammation | Q38244059 | ||
IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes | Q38329713 | ||
Stratum Corneum Lipids: Their Role for the Skin Barrier Function in Healthy Subjects and Atopic Dermatitis Patients. | Q38722792 | ||
In vitro assessment of IL-4- or IL-13-mediated changes in the structural components of keratinocytes in mice and humans | Q39053919 | ||
Antagonistic effect of the inflammasome on thymic stromal lymphopoietin expression in the skin. | Q39109165 | ||
IL-31 regulates differentiation and filaggrin expression in human organotypic skin models | Q39427021 | ||
The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch | Q40153067 | ||
Endogenous antimicrobial peptides and skin infections in atopic dermatitis | Q40698186 | ||
Transcriptional Analysis of Hair Follicle-Derived Keratinocytes from Donors with Atopic Dermatitis Reveals Enhanced Induction of IL32 Gene by IFN-γ. | Q41616682 | ||
TH2 cytokines increase kallikrein 7 expression and function in patients with atopic dermatitis. | Q41877936 | ||
A critical role for hemolysins and bacterial lipoproteins in Staphylococcus aureus-induced activation of the Nlrp3 inflammasome | Q41883050 | ||
Alteration of tight junction proteins is an early event in psoriasis: putative involvement of proinflammatory cytokines | Q42458101 | ||
Characterization of a human epidermis model reconstructed from hair follicle keratinocytes and comparison with two commercially models and native skin | Q42462994 | ||
Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells | Q42767760 | ||
CD8(+) T cells in the lesional skin of atopic dermatitis and psoriasis patients are an important source of IFN-γ, IL-13, IL-17, and IL-22. | Q42874986 | ||
Chemokines induce eosinophil degranulation through CCR-3. | Q43507013 | ||
Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis. | Q44758838 | ||
TSLP produced by keratinocytes promotes allergen sensitization through skin and thereby triggers atopic march in mice | Q44998295 | ||
Sensitization via healthy skin programs Th2 responses in individuals with atopic dermatitis. | Q50907995 | ||
Epidermal tight junction barrier function is altered by skin inflammation, but not by filaggrin-deficient stratum corneum. | Q52992376 | ||
Intrinsic alterations of pro-inflammatory mediators in unstimulated and TLR-2 stimulated keratinocytes from atopic dermatitis patients. | Q53258054 | ||
Mechanism of HBD-3 deficiency in atopic dermatitis. | Q53595910 | ||
Expression of IL-31 gene transcripts in NC/Nga mice with atopic dermatitis. | Q54414316 | ||
Overview of the interleukin-1 family of ligands and receptors. | Q54536457 | ||
Epicutaneous application of house dust mite induces thymic stromal lymphopoietin in nonlesional skin of patients with atopic dermatitis. | Q54789505 | ||
P433 | issue | 2 | |
P304 | page(s) | 234-245 | |
P577 | publication date | 2017-02-13 | |
P1433 | published in | Journal of Pathology | Q400296 |
P1476 | title | IL-1β induces thymic stromal lymphopoietin and an atopic dermatitis-like phenotype in reconstructed healthy human epidermis | |
P478 | volume | 242 |
Q90713975 | 3'-Sialyllactose prebiotics prevents skin inflammation via regulatory T cell differentiation in atopic dermatitis mouse models |
Q92246790 | 3D-Organotypic Cultures to Unravel Molecular and Cellular Abnormalities in Atopic Dermatitis and Ichthyosis Vulgaris |
Q55129443 | A murine model of atopic dermatitis can be generated by painting the dorsal skin with hapten twice 14 days apart. |
Q95322482 | Caffeoyl-Pro-His amide relieve DNCB-Induced Atopic Dermatitis-Like phenotypes in BALB/c mice |
Q92776774 | Spontaneous atopic dermatitis in mice with a defective skin barrier is independent of ILC2 and mediated by IL-1β |
Q89900908 | Thymic stromal lymphopoietin protects in a model of airway damage and inflammation via regulation of caspase-1 activity and apoptosis inhibition |